The impact of feasibility studies depends of their profitability but also their likelihood of getting the Capex finance. RED is a monster but a low grade high Capex beast, rather like Capricorn (CMM). They both brought out their feasibility studies showing large free cash flows but the market reaction was one of skepticism. Is it fundable? In both cases the market reaction was overly cautious, CMM is now a $1.3B company ad RED is $577m. Rox is valued at less than $44m. Rox has the Capex dilemma front and centre in mind imo. They will be restarting Youanmi with the smallest scale mill and lowest possible Capex requirement. When they bring out their Scoping Study the likely market reaction imo will be that they actually can raise the finance and restart Youanmi.
RXL Price at posting:
25.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)